If you liked this article you might like

The Nominees for Best Biopharma CEO of 2015 Are...

The Nominees for Best Biopharma CEO of 2015 Are...

Jim Cramer -- Valeant's Sales Struggles Mean Allergan Could Profit

Jim Cramer -- Valeant's Sales Struggles Mean Allergan Could Profit

Pfizer's Bid for Allergan May Be Too Good to Turn Down

Pfizer's Bid for Allergan May Be Too Good to Turn Down

Allergan Beats Earnings, Delays Forecast Until Next Quarter